Pharmacologic interventions

Child and Adolescent Psychiatric Clinics of North America

Volumn 5, Issue 4, 1996, Pages 853-880

  Bregman, J D ^a  

^a INSTITUTE OF LIVING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXAPINE; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; CENTRAL STIMULANT AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; LITHIUM; LORAZEPAM; NALTREXONE; NEUROLEPTIC AGENT; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; THIORIDAZINE; TIOTIXENE; VALPROIC ACID;

AGGRESSION; AUTOMUTILATION; CLINICAL TRIAL; DEPRESSION; EXTRAPYRAMIDAL SYMPTOM; FRAGILE X SYNDROME; GASTROINTESTINAL SYMPTOM; HUMAN; HYPONATREMIA; MENTAL DEFICIENCY; MENTAL DISEASE; MINIMAL BRAIN DYSFUNCTION; PRADER WILLI SYNDROME; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RETT SYNDROME; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SOCIAL PSYCHOLOGY; STEREOTYPY;

EID: 0029823739     PISSN: 10564993     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1056-4993(18)30337-7     Document Type: Review

References (123)

1. Aman M.G. Efficacy of psychotropic drugs for reducing self-injurious behavior in the developmental disabilities Ann Clin Psychiatry 5 1993 171 188
2. Aman M.G. Instruments for assessing treatment effects in developmentally disabled populations Assessment in Rehabilitation and Exceptionality 1 1994 1 20
3. Aman M.G. White A.J. Thioridazine dose effects with reference to stereotypic behavior in mentally retarded residents J Autism Dev Disord 18 1988 355 366
4. Aman M.G. White A.J. Field C. Chlorpromazine effects on stereotypic and conditioned behavior of severely retarded patients: A pilot study Journal of Mental Deficiency Research 28 1984 253 260
5. Aman M.G. Kern R.A. Mc Ghee D.E. Fenfluramine and methylphenidate in children with mental retardation and ADHD: Clinical and side effects J Am Acad Child Adolesc Psychiatry 32 1993 851 859
6. Aman M.G. Kern R.A. Mc Ghee D.E. Fenfluramine and methylphenidate in children with mental retardation and attention deficit hyperactivity disorder: Laboratory effects J Autism Dev Disord 23 1993 491 506
7. Aman M.G. Marks R.E. Turbott S.H. Clinical effects of methylphenidate and thioridazine in intellectually subaverage children J Am Acad Child Adolesc Psychiatry 30 1991 246 256
8. Aman M.G. Marks R.E. Turbott S.H. Methylphenidate and thioridazine in the treatment of intellectually subaverage children: Effects on cognitive-motor performance J Am Acad Child Adolesc Psychiatry 30 1991 816 824
9. Aman M.G. Richmond G. Stewart A.W. The aberrant behavior checklist: Factor structure and the effect of subject variables in American and New Zealand facilities American Journal of Mental Deficiency 91 1987 570 578
10. Aman M.G. Teehan C.J. White A.J. Haloperidol treatment with chronically medicated residents: Dose effects on clinical behavior and contingencies Am J Ment Retard 4 1989 452 460
11. Aman M. White A. Vaithianathan C. Preliminary study of imipramine in profoundly retarded residents J Autism Dev Disord 16 1986 263 273
12. Amin P. Yeragani V.K. Control of aggressive and self-mutilative behavior in a mentally retarded patient with lithium Can J Psychiatry 32 1987 162 163
13. Baumeister A.A. Todd M.E. Sevin J.A. Efficacy and specificity of pharmacological therapies for behavioral disorders in persons with mental retardation Clin Neuropharmacol 16 1993 271 294
14. Beck D.C. Carlson G.A. Russell A.T. Use of depression rating instruments in developmentally and educationally delayed adolescents J Am Acad Child Adolesc Psychiatry 26 1987 97 100
15. Beckwith B.E. Parker L. Pawlarczyk D. The dexamethasone suppression test in depressed adults: Preliminary findings Biol Psychiatry 20 1985 825 831
16. Benavidez D.A. Matson J.L. Assessment of depression in mentally retarded adolescents Res Dev Disabil 14 1993 179 188
17. Benjamin E. Bout-Smith T. Naltrexone and fluoxetine in Prader-Willi Syndrome J Am Acad Child Adolesc Psychiatry 32 1993 870 873
18. Bihm E.M. Poindexter A.R. Cross-validation of the factor structure of the aberrant behavior checklist for persons with mental retardation Am J Ment Retard 96 1991 209 211
19. Bodfish J.W. Madison J.T. Diagnosis and fluoxetine treatment of compulsive behavior disorder of adults with mental retardation Am J Ment Retard 98 1993 360 367
20. Boyd R.D. Neuroleptic malignant syndrome and mental retardation: Review and analysis of 29 cases Am J Ment Retard 98 1993 143 155
21. Bregman J.D. Harris J.C. Mental retardation Kaplan H.I. Sadock B.J. Comprehensive Textbook of Psychiatry, ed VI. 1995 Williams and Wilkins Baltimore 2207 2241
22. Bregman J.D. Leckman J.F. Ort S.I. Fragile-X syndrome: Genetic predisposition to psychopathology J Autism Dev Disord 18 1988 343 354
23. Brodtkorb E. Sand T. Strandjord R.E. Neuroleptic and antiepileptic treatment in the mentally retarded Seizure 2 1993 205 211
24. Chamberlain R.S. Herman: A novel biochemical model linking dysfunctions in brain melatonin, proopiomelanocortin, peptides, and serotonin in autism Biol Psychiatry 28 1990 773 793
25. Cohen I.L. Tsiouris J.A. Pfadt A. Effects of long-acting propranolol on agonistic and stereotyped behaviors in a man with pervasive developmental disorder and fragile X syndrome: A double-blind, placebo-controlled study [letter] J Clin Psychopharmacol 11 1991 398 399
26. Cook E.H. Rowlett R. Jaselskis C. Fluoxetine treatment of children and adults with autistic disorder and mental retardation J Am Acad Child Adolesc Psychiatry 31 1992 739 745
27. Craft M.J. Schiff A.A. Psychiatric disturbance in mentally handicapped patients Br J Psychiatry 137 1980 250 255
28. Craft M. Ismail I.A. Krishnamurti D. Lithium in the treatment of aggression in mentally handicapped patients: A double-blind trial Br J Psychiatry 150 1987 685 689
29. Einfeld S.L. Tonge B.J. Psychometric and clinical assessment of psychopathology in developmentally disabled children Australian and New Zealand Journal of Developmental Disabilities 17 1991 147 154
30. Elliott R.L. Lithium treatment and cognitive changes in two mentally retarded patients J Nerv Ment Dis 174 1986 689 692
31. Farren C.K. Dinan T.G. Dyskinesia in mentally handicapped women: Relationship to level of handicap, age, and neuroloptic exposure Acta Psychiatr Scand 90 1994 210 213
32. Feinstein C. Kammer Y. Barrett R. The assessment of mood and affect in developmentally disabled children and adolescents: The emotional disorders rating scale Res Dev Disabil 9 1988 109 121
33. Field C.J. Aman M.G. White A.J. A single-subject study of imipramine in a mentally retarded woman with depressive symptoms Journal of Mental Deficiency Research 30 1985 191
34. Friedman D.L. Kastner T. Plummer A.T. Adverse behavioral effects in individuals with mental retardation and mood disorders treated with carbamazepine Am J Ment Retard 96 1992 541 546
35. Fukuda K. Toshikuni E. Okuma T. Affective disorders in mentally retarded adolescents: Report of two cases with lithium treatment Japanese Journal of Psychiatry 40 1986 551 557
36. Gadow K. Prevalence and efficacy of stimulant drug use with mentally retarded children and youth Psychopharmacol Bull 21 1985 291 303
37. Gaind G.S. Rosebush P.I. Mazurek M.F. Lorazepam treatment of acute and chronic catatonia in two mentally retarded brothers J Clin Psychiatry 55 1994 20 23
38. Garber H.J. Mc Gonigle J.J. Slomka G.T. Treatment of stereotypic behaviors and self-injury in patients with developmental disabilities J Am Acad Child Adolesc Psychiatry 31 1992 1157 1160
39. Gath A. Gumley D. Behaviour problems in retarded children with special reference to Down’s syndrome Br J Psychiatry 149 1986 68 74
40. Gillberg C. Terenius L. Lonnerholm G. Endorphin activity in childhood psychosis Arch Gen Psychiatry 42 1985 780 783
41. Gillberg C. Persson E. Grufman M. Psychiatric disorders in mildly and severely mentally retarded urban children and adolescents: Epidemiological aspects Br J Psychiatry 149 1986 68 74
42. Glue P. Rapid cycling affective disorders in the mentally retarded Biol Psychiatry 26 1989 250 256
43. Gross E.J. Hull H.G. Lytton G.J. Case study of neuroleptic-induced akathisia: Important implications for individuals with mental retardation Am J Ment Retard 98 1993 156 164
44. Hagerman RJ, Murphy MA, Wittenberger MD: A controlled trial of stimulant medication in children with fragile X syndrome 30:377-392, 1988
45. Hancock R.D. Weber S.L. Kaza R. Changes in psychotropic drug use in longterm residents of an ICF/MR facility Am J Ment Retard 96 1991 137 141
46. Handen B.L. Breaux A.M. Gosling A. Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorder Pediatrics 86 1990 922 930
47. Handen B.L. Breaux A.M. Janosky J. Effects and noneffects of methylphenidate in children with mental retardation and ADHD J Am Acad Child Adolesc Psychiatry 31 1992 455 561
48. Handen B.L. Feldman H. Gosling A. Adverse side effects of ritalin among mentally retarded children with ADHD J Am Acad Child Adolesc Psychiatry 30 1991 241 245
49. Handen B.L. Janosky J. Mc Auliffe S. Prediction of response to methylphenidate among children with ADHD and mental retardation J Am Acad Child Adolesc Psychiatry 33 1994 1185 1193
50. Harper E.C. Wadsworth J.S. Behavioral problems and medication utilization Ment Retard 31 1993 97 103
51. Heistad G. Zimmermann R. Double-blind assessment of Mellaril in a mentally retarded population using detailed evaluations Psychopharmacol Bull 15 1979 86 88
52. Herman B.H. Hammock M.K. Arthur-Smith A. Role of opioid peptides in autism: Effects of acute administration of naltrexone Neuroscience 12 1986 1172
53. Hilton D.K. Martin C.A. Heffron W.M. Imipramine treatment of ADHD in a fragile X child J Am Acad Child Adolesc Psychiatry 30 1991 831 834
54. Howland R.H. Fluoxetine treatment of depression in mentally retarded adults J Nerv Ment Dis 180 1992 202 205
55. Iverson J.C. Fox R.A. Prevalence of psychopathology among mentally retarded adults Res Dev Disabil 10 1989 77 83
56. Jerome L. Prader-Willi and bipolar illness [letter] J Am Acad Child Adolesc Psychiatry 32 1993 876 877
57. Kalachnik J.E. Sprague R.L. The Dyskinesia Identification System Condensed User Scale (DISCUS): Reliability, validity, and a total score cut-off for mentally ill and mentally retarded populations J Clin Psychol 49 1993 177 189
58. Kars H. Broekema W. Glaudemans-van Gelderen I. Naltrexone attenuates self-injurious behavior in mentally retarded subjects Biol Psychiatry 27 1990 741 746
59. Kastner T.A. Walsh K. Interdisciplinary team review of psychotropic drug use in community settings [comment] Ment Retard 32 1994 243 245
60. Kastner T. Finesmith R. Walsh K. Long-term administration of valproic acid in the treatment of affective symptoms in people with mental retardation J Clin Psycho-pharmacol 13 1993 448 451
61. Kastner T. Friedman D.L. Pond W.S. Carbamazepine-induced hyponatremia in patients with mental retardation Am J Ment Retard 96 1992 536 540
62. Kovacs M: Rating scales to assess depression in school aged children. Acta Paedo-psychiatrica 305-315, 1981
63. Langee H.R. Conlon M. Predictors of response to antidepressant medications Am J Ment Retard 97 1992 65 70
64. Lepler S. Hodas A. Cotter-Mack A. Implementation of an interdisciplinary psychotropic drug review process for community-based facilities Ment Retard 31 1993 307 315
65. Lindsay W.R. Michie A.M. Adaptation of the Zung self-rating anxiety scale for people with a mental handicap Journal of Mental Deficiency Research 32 1988 485 490
66. Linter C.M. Short-cycle manic-depressive psychosis in a mentally handicapped child without family history Br J Psychiatry 151 1987 554 555
67. Lund J. The presence of psychiatric morbidity in mentally retarded adults Acta Psychiatr Scand 72 1985 563 570
68. Lund J. Psychiatric aspects of Down’s syndrome Acta Psychiatr Scand 78 1988 369 374
69. Markowitz P.I. Effect of fluoxetine on self-injurious behavior in the developmentally disabled: A preliminary study J Clin Psychopharmacol 12 1992 27 31
70. Matson J.L. The PIMRA Manual 1988 International Diagnostic Systems Orlando Park, IL
71. Matson J.L. Barrett R.P. Helsel W.J. Depression in mentally retarded children Res Dev Disabil 9 1988 39 46
72. Matson J.L. Gardner W.I. Coe D.A. A scale for evaluating emotional disorders in severely and profoundly mentally retarded persons: Development of the diagnostic assessment for the severely handicapped (DASH) scale Br J Psychiatry 159 1991 404 409
73. Mc Cracken J.T. Diamond R.P. Bipolar disorder in mentally retarded adolescents J Am Acad Child Adolesc Psychiatry 27 1988 494 499
74. Menolascino P. Wilson J. Golden C. Medication and treatment of schizophrenia in persons with mental retardation Ment Retard 24 1986 277 283
75. Mikkelsen E. Low-dose haloperidol for stereotypic self-injurious behavior in the mentally retarded [letter] N Engl J Med 315 1986 398 399
76. Millichamp C.J. Singh N.N. The effects of intermittent drug therapy on stereotypy and collateral behaviors of mentally retarded persons Res Dev Disabil 8 1987 213 227
77. Pary R. Psychoactive drugs used with adults and elderly adults who have mental retardardation Am J Ment Retard 98 1993 121 127
78. Pary R. Side effects during lithium treatment for psychiatric disorders in adults with mental retardation Am J Ment Retard 96 1991 269 273
79. Pawlarcyzk D. Beckwith B. Depressive symptoms displayed by persons with mental retardation: A review Ment Retard 25 1987 325 330
80. Payton J.B. Burkhart J.E. Herson M. Treatment of ADDH in mentally retarded children: A preliminary study J Am Acad Child Adolesc Psychiatry 28 1989 761 767
81. Percy A.K. Glaze D.G. Schultz R.J. Rett syndrome: Controlled study of an oral opiate antagonist, naltrexone Ann Neurol 35 1994 464 470
82. Pirodsky D.M. Gibbs J.W. Hesse R.A. Use of the dexamethasone suppression test to detect depressive disorders of mentally retarded individuals American Journal of Mental Deficiency 90 1985 245 252
83. Poindexter A.R. Berglund J.A. Kolstoe P.D. Changes in antiepileptic drug prescribing patterns in large institutions: Preliminary results of a five-year experience Am J Ment Retard 98 1993 32 40
84. Prout H.T. Strohmer D.C. Emotional Problem Scales: Self Report Inventory 1991 Genium Publishing Corporation Schenectady, NY
85. Ratey J. Mikkelsen E. Smith G. Beta-blockers in the severely and profoundly mentally retarded J Clin Psychopharmacol 6 1986 103 107
86. Ratey J.J. Sovner R. Mikkelsen E. Buspirone therapy for maladaptive behavior and anxiety in developmentally disabled persons J Clin Psychiatry 50 1989 382 384
87. Reid A.H. Ballinger B.R. Personality disorder in mental handicap Psychol Med 17 1987 983 987
88. Reid A.H. Naylor G.J. Kay D.S.G. A double-blind, placebo controlled, crossover trial of carbamazepine in overactive, severely, mentally handicapped patients Psychol Med 11 1981 109 113
89. Reiss S. Test manual for the Reiss Screen for Maladaptive Behavior 1988 International Diagnostic Systems Orland Park, IL
90. Reynolds W.M. Self-Report Depression Questionnaire (SRDQ) administration booklet 1989 Psychological Assessment Resources Odessa, FL
91. Reynolds W.M. Miller K.L. Depression and learned helplessness in mentally retarded and nonmentally retarded adolescents: An initial investigation Applied Research in Mental Retardation 6 1985 295 306
92. Richardson M. Haugland M. Pass R. The prevalence of tardive dyskinesia in a mentally retarded population Psychopharmacol Bull 22 1986 243 249
93. Ricketts R.W. Goza A.B. Ellis C.R. Fluoxetine treatment of severe self-injury in young adults with mental retardation J Am Acad Child Adolesc Psychiatry 32 1993 865 869
94. Rivinus T. Harmatz J. Diagnosis and lithium treatment of affective disorder in the retarded: Five case studies Am J Psychiatry 136 1979 551 554
95. Rojahn J. Warren V.J. Ohringer S. A comparison of assessment methods for depression in mental retardation J Autism Dev Disord 24 1994 305 313
96. Ruedrich S.L. Wilkinson L. Atypical unipolar depression in mentally retarded patients: Amoxapine treatment J Nerv Ment Dis 180 1992 206 207
97. Rutter M. Psychological sequelae of brain damage in children Am J Psychiatry 138 1981 1533 1544
98. Rutter M. Graham P. Yule W. A Neuropsychiatric Study in Childhood: Clinics in Developmental Medicine 1970 Heinemann Medical Books London
99. Sachdev P. Drug-induced movement disorders in institutionalized adults with mental retardation: Clinical characteristics and risk factors Australian and New Zealand Journal of Psychiatry 26 1992 242 248
100. Sajatovic M. Ramirez L.F. Kenny J.J. The use of clozapine in borderline intellectual functioning and mentally retarded schizophrenic patients Compr Psychiatry 35 1994 29 33
101. Sandman C.A. Barron J.L. Chicz-De Met A. Brief report: Plasma B-endorphin and cortisol levels in autistic patients J Autism Dev Disord 21 1991 1
102. Schaal D.W. Hackenberg T. Toward a functional analysis of drug treatment for behavior problems of people with developmental disabilities Am J Ment Retard 99 1994 123 140
103. Senatore V. Matson J.L. Kazdin A.E. An inventory to assess psychopathology of mentally retarded adults American Journal of Mental Deficiency 89 1985 456 459
104. Singh I. Owino W.J.E. A double-bind comparison of zuclopenithixol tablets with placebo in the treatment of mentally handicapped in-patients with associated behavioural disorders J Intellect Disabil Res 36 1992 541 549
105. Sovner R. The use of valproate in the treatment of mentally retarded persons with typical and atypical bipolar disorders J Clin Psychiatry 50 1989 40 43
106. Sovner R. Hurley A. The management of chronic behavior disorders in mentally retarded adults with lithium carbonate J Nerv Ment Dis 169 1981 191
107. Sovner R. Fox C.J. Lowry M.J. Fluoxetine treatment of depression and associated self-injury in two adults with mental retardation J Intellect Disabil Res 37 1993 301 311
108. Spreat S. Behar D. Reneski B. Lithium carbonate for aggression in mentally retarded persons Compr Psychiatry 30 1989 505 511
109. Spreat S. Serafin C. Behar D. Tranquilizer reduction trials in a residential program for persons with mental retardation Hosp Comm Psychiatry 44 1993 1100 1102
110. Stein D.J. Keating J. Zar H.J. A survey of the phenomenology and pharmacotherapy of compulsive and impulsive-aggressive symptoms in Prader-Willi Syndrome J Neuropsychiatry Clin Neurosci 6 1994 23 29
111. Steingard R. Biederman J. Lithium responsive manic-like symptoms in two individuals with autism and mental retardation J Am Acad Child Adolesc Psychiatry 26 1987 932 935
112. Szymanski L.S. Kedesdy J. Sulkes S. Naltrexone in treatment of self injurious behavior: A clinical study Res Dev Disabil 8 1987 179 190
113. Thompson T. Hackenberg T. Cerutti D. Opioid antagonist effects on self-injury in adults with mental retardation: Response form and location as determinants of medication effects Am J Ment Retard 99 1994 85 102
114. Tiihonin J. Hakola P. Paanila J. Eltoprazine for aggression in schizophrenia and mental retardation [letter] Lancet 341 1993 307
115. Tu J.B. Hartridge C. Izawa J. Psychopharmacogenetic aspects of Prader-Willi syndrome J Am Acad Child Adolesc Psychiatry 31 1992 1137 1140
116. Tyrer S.P. Walsh A. Edwards D.E. Factors associated with a good response to lithium in aggressive mentally handicapped subjects Prog Neuropsychopharmacol Biol Psychiatry 8 1984 751 755
117. Vanden Borre R. Vermote R. Buttiens M. Risperidone as add-on therapy in behavioural disturbances in mental retardation: A double-blind placebo-controlled cross-over study Acta Psychiatr Scand 87 1993 167 171
118. Vitiello B. Spreat S. Obsessive-compulsive disorder in mentally retarded patients J Nerv Ment Disord 177 1989 232 236
119. Warnock J.K. Kestenbaum T. Pharmacologic treatment of severe skin-picking behaviors in Prader-Willi syndrome Arch Dermatol 128 1992 1623 1625
120. Weizman R. Weizman A. Tyano S. Humoral-endorphin blood levels in autistic, schizophrenic and healthy subjects Psychopharmacology 82 1984 368 370
121. Whitman B.Y. Accardo P. Emotional symptoms in Prader-Willi syndrome adolescents Am J Med Genet 28 1987 897 905
122. Williams D.T. Mehl R. Yudofsky S. The effects of propranolol on uncontrolled rage outbursts in children and adolescents with organic brain dysfunction J Am Acad Child Psychiatry 21 1982 129 135
123. Zigler E. Burak J.A. Personality development and the dually diagnosed person Res Dev Disabil 10 1989 225 240